Your email has been successfully added to our mailing list.

×
-0.000323206205559197 -0.000484809308338738 -0.000565610859728566 -0.000565610859728566 -0.00161603102779576 -0.00202084680025859 -0.000736910148674859 0.00145442792501622
Stock impact report

Eli Lilly's Mounjaro, Zepbound to remain in shortage through end of Q2 [Seeking Alpha]

Novo Nordisk A/S (NVO) 
Last novo nordisk a/s earnings: 2/5 01:31 am Check Earnings Report
US:NYSE Investor Relations: novonordisk.com/investors.html
Company Research Source: Seeking Alpha
The U.S. FDA Wednesday updated the drug shortage status for the two medications. Only one dosage strength of Mounjaro and Zepbound have normal availability. Tirzepatide, a dual GIP/GLP-1 receptor co-agonist, has proven to be one of Lilly's most successful recent drug launches . While the drug more recently won approval as a weight loss therapy (Zepbound), Mounjaro was being used off label for weight loss prior. Novo Nordisk's ( NVO ) competing GLP-1 weight loss therapy, Wegovy (semaglutide), is also in shortage, with four out of five dosage strengths having limited availability. The FDA said that the estimated shortage duration is to be determined. Ozempic, which also contains semaglutide but is approved for diabetes, is not in shortage. Recommended For You More Trending News Recommended For You More Trending News Show less Read more
Impact Snapshot
Event Time:
NVO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for NVO alerts
Opt-in for
NVO alerts

from News Quantified
Opt-in for
NVO alerts

from News Quantified